Neuroimaging and the Investigation of Drug-Drug Interactions Involving Psychedelics

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Psychedelic therapies are emerging psychiatric treatments with significant potential.
• Little is known about their interactions with common psychiatric medications.
• Integration into existing treatment models necessitates understanding drug-drug interactions.

Purpose of the Study:

• To outline challenges in studying psychedelic drug-drug interactions.
• To summarize current key findings on these interactions.
• To propose multimodal neuroimaging as a way forward.

Main Methods:

• Review of existing literature on psychedelic drug-drug interactions.
• Discussion of challenges in current research methodologies.
• Proposal for multimodal neuroimaging (PET, fMRI) and ancillary measures.

Main Results:

• Current understanding of psychedelic drug-drug interactions is limited.
• Awareness of potential interactions is vital for clinical integration.
• Multimodal neuroimaging offers a comprehensive approach to assessment.

Conclusions:

• Further research is critical to understand psychedelic drug-drug interactions.
• Multimodal neuroimaging is essential for a comprehensive assessment.
• This approach will inform safe and effective clinical integration of psychedelic therapies.